Cargando…
073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform
Autores principales: | Langan, S., Smith, C., Collaborative, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672437/ http://dx.doi.org/10.1016/j.jid.2022.09.083 |
Ejemplares similares
-
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
por: MacKenna, Brian, et al.
Publicado: (2022) -
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England
por: Andrews, Colm, et al.
Publicado: (2022) -
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform
por: Zheng, Bang, et al.
Publicado: (2022) -
Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform
por: Wing, Kevin, et al.
Publicado: (2022) -
Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform
por: Williamson, Elizabeth J., et al.
Publicado: (2022)